Refine by
Blood Loss Articles & Analysis
24 news found
The use of the exoscope resulted in shorter operative time, reduced blood loss, shorter length of stay and favorable clinical outcomes compared to the use of the operative microscope: 19% reduction in operative time (83 mins vs 132 mins; p=0.006) 40% reduction in length of stay (1.04 days vs 1.73 days; p=0.02) 79% reduction in blood ...
Furthermore, exoscopes have been shown to increase the ability to perform MIS procedures, reduce pain and fatigue for surgeons, reduce blood loss during procedures, and reduce OR time when compared to operative microscopes (Nawabi et al., 2023). ...
The infrared coagulator with its multiple-sized tips and pinpoint accuracy has proven to be superior (especially in a wet field) in providing excellent hemostasis, allowing minimal blood loss, and in allowing the clearest visual field in pe,forming both hair transplant and scalp reduction surgery. ...
Today’s devices focus on maternal heart rate, fetal heart rate and contractions with no available technology to successfully detect PPH before significant blood is lost. Founder Dr Sarah McDonald said genuine innovation in the maternal-fetal monitoring space has not been seen since the 1960’s, with latest advancements focused on repackaging old devices in a sleek ...
When compared with the open technique, the minimally invasive approach can result in decreased pain and blood loss as well as a shorter length of hospitalization. However, the narrower working channel in the MIS technique increases the difficulty of decortication and bone grafting. ...
The NEURESCUE device is the world’s first intelligent balloon catheter for aortic occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the aorta to redirect blood flow towards the upper ...
No other critical care blood gas analyzer has this unique capability. Low MCHC, associated with hypochromic anemias, can indicate internal bleeding, anemia of chronic disease, chronic low grade blood loss, iron deficiency, and thalassemia. ...
The Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies such as cardiac arrest. ...
“Our organization is focused on making a difference by helping hospitals improve their clinical outcomes and stem their financial losses from blood culture contaminations. It is rewarding to see our efforts recognized by others. ...
Lipella Pharmaceuticals promotes awareness of hemorrhagic cystitis, a chronic painful syndrome that can be acquired by cancer patients who have received pelvic radiation therapy. PITTSBURGH, November 12, 2020 – During this November, Bladder Health Awareness Month, we promote the awareness of a serious bladder health condition, hemorrhagic cystitis, which affects many cancer survivors who ...
A multi-site, prospective, open-label, dose-escalation clinical trial assessing the safety and efficacy of LP-10 (liposomal tacrolimus) is now open for recruitment at several sites. PITTSBURGH, October 15, 2020 (BUSINESS WIRE) – Lipella Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on improving cancer survivorship, today announced it has begun recruiting patients in ...
Gauss, the leader in AI-enabled surgical applications, announced an over-the-air software update, Triton QBL, that pairs the company’s AI-powered blood loss monitor with integrated protocols and provider alerts that help to synchronize postpartum hemorrhage care. ...
Endomedix, Inc., today announced that it will present its patented revolutionary technology to control bleeding in battlefield injuries at the upcoming Military Health System and Research Symposium (MHSRS) annual meeting. Loss of blood still remains the most common cause of potentially preventable deaths in battlefield casualties, two-thirds of such deaths ...
Researchers at Mount Sinai Hospital (New York, NY) studied over 7,600 deliveries and concluded in “The association between the introduction of quantitative assessment of postpartum blood loss and institutional changes in clinical practice: an observational study” (Katz D, et al.) that the systematic monitoring of blood ...
The company’s flagship product, Triton, monitors surgical blood loss in real time using digital imaging and machine learning on the iPad. ...
The company’s flagship product, Triton, monitors surgical blood loss in real time using digital imaging and machine learning on the iPad. ...
“Since this device doesn’t violate the rotator cuff and can be inserted with reduced operative time and blood loss, it relieves pain and restores function more effectively than alternative treatments, in my experience. ...
Conversely, underestimation of blood loss has been recognized as one of largest factors driving post-partum hemorrhage due to delayed recognition and intervention. ...
Gauss Surgical, Inc. announced today that the company has received CE (Conformité Européenne) Mark for its Triton System™ for iPad, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. This milestone allows Gauss to market and sell its system throughout Europe and other regions that require the CE ...
The company will have the opportunity to present Triton, the world’s first and only mobile platform for real-time monitoring of surgical blood loss, to the nearly 2,000 health care professionals in attendance. ...